20
Jul 2026
Dissolving microneedles could improve photodynamic skin cancer treatment
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells.
Stay Informed!
20
Jul 2026
New target makes cancer cells vulnerable to immune destruction
Researchers at the University of Illinois Chicago have identified a molecular switch that helps determine whether cancer cells remain soft and difficult to destroy or become stiff enough for the immune system to attack.
20
Jul 2026
Stroke patients with disabilities may benefit from thrombectomy treatment
Patients with moderate-to-severe disabilities before a stroke are frequently excluded from endovascular thrombectomy (EVT), despite representing a substantial proportion of patients with large vessel occlusion stroke.
20
Jul 2026
AI-guided technique improves targeted therapy delivery for brain tumors
Researchers presented a groundbreaking artificial intelligence (AI)-guided technique today at the Society of NeuroInterventional Surgery's (SNIS) 23rd Annual Meeting that may improve the accuracy of delivering experimental therapies directly to malignant brain tumors.
20
Jul 2026
Female doctors request more diagnostic tests in emergency departments
A new UCLA Health study examining more than 1.5 million emergency department (ED) visits found that female physicians request more imaging and laboratory tests and admit more patients to the hospital than their male counterparts working alongside them.
20
Jul 2026
Study reveals geographic gaps in breastfeeding initiation across America
A nationwide analysis led by a UC Riverside (Calif.) professor provides one of the clearest pictures yet of where mothers are least likely to begin breastfeeding their babies in the United States and what circumstances associate with lower rates.
20
Jul 2026
Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference
Researchers compared semaglutide with liraglutide in 57,456 insured adults without recorded diabetes or cardiovascular disease who initiated formulations indicated for chronic weight management. Semaglutide users had a lower risk of incident diabetes, particularly beyond six months of follow-up, but limited cardiovascular events prevented a precise comparison of cardiovascular risk.
20
Jul 2026
Beetroot juice shows its clearest aerobic benefits in recreational exercisers
A meta-analysis of 38 placebo-controlled trials involving 703 participants found that beetroot juice supplementation was associated with a small improvement in VO2max or VO2peak during aerobic exercise. Benefits were most consistent in recreationally active adults, while evidence in highly trained athletes remained limited and uncertain.
20
Jul 2026
Semaglutide fuels rapid growth in US GLP-1RA use as payments rise
Nationally representative US data show GLP-1RA use rose 230% among adults with diabetes and 643% among those without reported diabetes between 2017 and 2022, largely driven by semaglutide. Mean annual out-of-pocket payments decreased, but mean total annual payments per user increased, raising concerns about long-term affordability.
20
Jul 2026
Gut microbial metabolites may shape vulnerability to stress-related mental disorders
Gut microbiome-derived metabolites may influence stress-related mental disorders through neural, immune, endocrine, and epigenetic pathways. Evidence is strongest for depression and preclinical models, while larger longitudinal human studies are needed to establish causality and clinical value.
